The anti-steatosis action of leptin has been shown in non-obese mice with type I diabetes, whereby leptin administration led to significant reductions of lipogenic transcription factors and decreased plasma and tissue lipids [73]. This evidence concerns the gene LEP and type 1 diabetes mellitus.